Marc Schwabish - Jun 20, 2024 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)

Role
Chief Business Officer
Signature
/s/ Daniel Lochner, Attorney-in-Fact
Stock symbol
TECX
Transactions as of
Jun 20, 2024
Transactions value $
$0
Form type
4
Date filed
6/24/2024, 04:25 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECX Employee Stock Option (Right to Buy) Award +91.2K 91.2K Jun 20, 2024 Common Stock 91.2K $2.38 Direct F1, F2, F3
transaction TECX Employee Stock Option (Right to Buy) Award +8.02K 8.02K Jun 20, 2024 Common Stock 8.02K $5.38 Direct F1, F4, F5
transaction TECX Employee Stock Option (Right to Buy) Award $0 +61.6K $0.00 61.6K Jun 20, 2024 Common Stock 61.6K $16.80 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Upon the closing of the Merger, each outstanding option to purchase shares of Tectonic common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock, on the same terms and conditions as were applicable to such Tectonic stock option prior to the Merger, as adjusted for the exchange ratio and the reverse stock split.
F2 The shares subject to the option vest as to 25% of the shares on March 15, 2022 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
F3 Received in exchange for a stock option to acquire 170,679 shares of Tectonic common stock pursuant to the Merger Agreement.
F4 The shares subject to the option vest in 48 equal monthly installments beginning on December 1, 2023, subject to the Reporting Person's continued service to the Issuer on each such vesting date
F5 Received in exchange for a stock option to acquire 15,000 shares of Tectonic common stock pursuant to the Merger Agreement.
F6 The shares subject to the option vest as to 25% of the shares on June 20, 2025 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.